Is a complete AIM/POLB research report available?

No complete published report is available for aim/POLB (AIM/POLB) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

AIM/POLB (AIM/POLB)

London Stock Exchange AIM: AIM/POLB · GBX

GBX 6.26

+0.11 (+1.8%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first AIM/POLB analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	47M
Net income (ttm)	-5.7M
EPS (ttm)	-GBX 0.01
Shares out	763.4M
Volume	1,144,522
Beta	1.81

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -5.7M
EPS (ttm): -GBX 0.01
Market cap: 47M

All AIM/POLB indicators

Market & fundamental data

Available fields

145

Groups with data

Currency

GBP

Showing 145 of 145 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	15
Employees Change	-1%
Employees Change Percent	-6.25
Enterprise value	GBX 39.2M
Exchange	London Stock Exchange AIM
Financial currency	GBP
First seen	2026-05-10
Industry	Biotechnology
Isin	GB00BKPG7Z60
Last refreshed	2026-07-30
Market cap	GBX 47M
Price	GBX 6.26
Price currency	GBX
Sector	Healthcare
Sector PE	21.25
Sector PE Fwd	14.65
Sic	2834
Symbol	aim/POLB
Website	https://www.poolbegpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-12.13%
P/B ratio	5.46x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	GBX -5.7M
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Profit Per Employee	GBX -379,667
ROA	-39.2
ROCE	-70.07
ROE	-63.72
ROIC	-44.28

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	123.69%
Cagr3y	-5.21%
Cagr5y	-10.25%
EPS Growth Quarters	3
EPS Growth Years	3
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	GBX 9.9M
Cash	GBX 7.7M
Current Assets	GBX 8.3M
Current Liabilities	GBX 1.3M
Debt	GBX 0
Equity	GBX 8.6M
Liabilities	GBX 1.3M
Long Term Assets	GBX 1.7M
Long Term Liabilities	GBX 0
Net Cash	GBX 7.7M
Net Cash By Market Cap	GBX 16.43
Net Cash Growth	-1.42%
Net Debt Equity	GBX -0.9
Tangible Book Value	GBX 6.9M
Tangible Book Value Per Share	GBX 0.01
WACC	14.22

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.17
Net Working Capital	GBX -786,000
Quick ratio	5.97
Working Capital	GBX 6.9M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-20.53%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	123.57%
200-day SMA	4.84
3Y total return	-14.83%
50-day SMA	6.76
50-day SMA vs 200-day SMA	50over200
5Y total return	-41.77%
All Time High	15.77
All Time High Change	-60.3%
All Time High Date	2024-05-07
All Time Low	2.25
All Time Low Change	178.22%
All Time Low Date	2025-04-07
ATR	0.34
Beta	1.81
Beta1y	0.59
Beta2y	0.96
Ch YTD	56.5
High	6.5
High52	9
High52 Date	2026-06-03
High52ch	-30.44%
Low	6.1
Low52	2.5
Low52 Date	2025-08-11
Low52ch	150.4%
Ma50ch	-7.42%
Price vs 200-day SMA	29.31%
RSI	44.46
RSI Monthly	53.55
RSI Weekly	56.47
Sharpe ratio	1.63x
Sortino ratio	3
Total Return	-20.53%
Tr YTD	56.5
Tr1m	-7.26%
Tr1w	2.62%
Tr3m	45.58%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX -6.3M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	558,589,054%
Shares Insiders	16.95%
Shares Institutions	52.02%
Shares Out	763,437,106
Shares Qo Q	37.95%
Shares Yo Y	20.53%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted OCF	-5,307,000
Average Volume	2,727,225.35x
Bv Per Share	0.01
Ch1m	-7.26
Ch1w	2.62
Ch1y	123.6
Ch3m	45.58
Ch3y	-14.83
Ch5y	-41.77
Ch6m	42.27
Change	1.79%
Change From Open	0.97
Close	6.15
Days Gap	0.81
Depreciation Amortization	59,000
Dollar Volume	7,164,707.7
Earnings Date	2026-09-18
EBIT	GBX -6M
EBITDA	GBX -6M
EPS	GBX -0.01
F Score	1
Financing CF	4,477,000
Fiscal Year End	December
Founded	2,021
Income Tax	GBX -79,000
Investing CF	173,000
Is Primary Listing	1
Last Earnings Date	2026-01-02
Last Report Date	2025-12-31
Ma150	5.2
Ma150ch	20.32%
Ma20	6.48
Ma20ch	-3.37%
Net CF	-111,000
Next Earnings Date	2026-09-18
Open	6.2
Position In Range	40
Price Date	2026-07-29
Ptbv Ratio	6.78
Relative Volume	0.42x
Share Based Comp	546,000
Tr6m	42.27%
Volume	1,144,522

AIM/POLB (AIM/POLB)

Coverage state: Market snapshot only — no published research

Generate the first AIM/POLB analysis

Price

Financial snapshot

Fair-value bridge

Latest news · AIM/POLB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AIM/POLB indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on AIM/POLB

Frequently asked questions